| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |